.Zevra Therapies' unusual illness drug seems to become on the road to permission this autumn after g...
.Pfizer's phase 3 Duchenne muscle dystrophy (DMD) gene therapy failing has blown a $230 million gap ...
.After much more than twenty years of deal with neurodegenerative ailments, Swiss biotech AC Immune ...
.GSK has actually ditched a period 2 individual papillomavirus (HPV) vaccine coming from its pipelin...
.OS Therapies will detail on the NYSE American stock substitution today using a $6.4 thousand IPO th...
.ALX Oncology's period 2 gastric cancer cells action cost has compromised. After seeing its own CD47...
.Yet Another of Ionis Pharmaceuticals' crucial midphase readouts has fallen short of requirements, c...
.While Biogen's pharma peers are seeking for late-stage properties along with little bit of risk, ch...
.Instil Biography has been a biotech seeking a pipeline after it junked its own lead properties over...
.Biogen has returned rights to a very early Alzheimer's health condition program to Denali Rehabs, g...